Posted inComunicati
REVA Medical Announces Positive MOTIV BTK Trial Results Showing Superiority in Patients with Critical Limb-Threatening Ischemia
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE MOTIV BTK randomized trial met primary efficacy endpoint, with early…









